XML 30 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY
 3 Months Ended
Sep. 30, 2013
STOCKHOLDERS' EQUITY [Abstract]  
STOCKHOLDERS' EQUITY
NOTE 6: - STOCKHOLDERS' EQUITY
 
From July 2013 through September 2013, a total of 457,000 warrants were exercised via "cashless" exercise, resulting in the issuance of 169,082 shares of common stock to investors of the Company.  In addition, 279,000 warrants were exercised for cash and resulted in the issuance of 279,000 shares of common stock to investors of the Company. The aggregate cash consideration received was $509. In addition, in August 2013, a total of 15,000 warrants were exercised via a "cashless" exercise, resulting in the issuance of 5,905 shares of common stock to a consultant of the Company.

 
a.
Options, warrants, restricted stock and restricted stock units to employees, directors and consultants:
 
 
1.
Options to employees and directors:
 
The Company has approved two incentive option plans from 2003 and from 2005 (the "2003 Plan" and the "2005 Plan", and collectively, the "Plans").

The Company accounted for its options to employees and directors under the fair value method in accordance with ASC 718, "Compensation - Stock Compensation". A summary of the Company's share option activity for options granted to employees and directors under the Plans is as follows:

   
Three months ended September 30, 2013 (Unaudited)
  
   
Number
    
Weighted Average Exercise Price
    
Weighted Average Remaining Contractual Terms (in years)
    
Aggregate Intrinsic Value Price
  
Options outstanding at beginning of period
     1,958,156     $ 4.01              
Options forfeited
     (50,000 )   $ 15.31              
Options outstanding at end of the period
     1,908,156     $ 3.73       3.82     $ 1,195  
Options exercisable at the end of the period
     1,908,156     $ 3.73       3.82     $ 1,195  
Options vested
     1,908,156     $ 3.73       3.82     $ 1,195  
 
Intrinsic value of exercisable options (the difference between the Company's closing stock price on the last trading day in the period and the exercise price, multiplied by the number of in-the-money options) represents the amount that would have been received by the employees and directors option holders had all option holders exercised their options on September 30, 2013. This amount changes based on the fair market value of the Company's common stock.

 
2.
Options and warrants to non-employees:

A summary of the Company's activity related to options and warrants to consultants is as follows:

   
Three months ended September 30, 2013 (Unaudited)
  
   
Number
    
Weighted Average Exercise Price
    
Weighted Average Remaining Contractual Terms (in years)
    
Aggregate Intrinsic Value Price
  
Options and warrants outstanding at beginning of period
     315,500     $ 4.40              
Options and warrants exercised
     (15,000 )     1.91              
Options and warrants outstanding at end of the period
     300,500     $ 4.56       3.97     $ 463  
                                 
Options and warrants exercisable at the end of the period
     299,000     $ 4.59       3.95     $ 458  
                                 
Options and warrants vested and expected to vest
     300,500     $ 4.56       3.97     $ 463  
 
Compensation expenses related to options and warrants granted to consultants were recorded as follows:
 
   
Three months ended
September 30,
  
   
2013
    
2012
  
   
Unaudited
  
Research and development expenses
   $ -     $ -  
General and administrative expenses
     2       18  
    $ 2     $ 18  
 
Future expenses related to options and warrants granted to consultants for an average time of approximately three months is $1.
 
 
3.
Restricted stock and restricted stock units to employees and directors:
 
During the three months ended September 30, 2013, the Company did not grant restricted stock units to any of the Company's employees and directors.
 
The following table summarizes the activities for unvested restricted stock units granted to employees and directors for the three months ended September 30, 2013 (Unaudited):

   
Number
  
Unvested at the beginning of period
     1,660,525  
Granted
     -  
Forfeited
     (20,873 )
Vested
     (202,189 )
Unvested at the end of the period
     1,437,463  
Expected to vest after September 30, 2013
     1,420,189  
 
Compensation expenses related to restricted stock units granted to employees and directors were recorded as follows:
 
   
Three months ended September 30,
  
   
2013
    
2012
  
   
Unaudited
  
Research and development expenses
   $ 126     $ 317  
General and administrative expenses
     1,048       608  
    $ 1,174     $ 925  
 
 
Future expenses related to restricted stock and restricted stock units granted to employees and directors for an average time of approximately 1.75 years is $2,586.
 
 
4.
Restricted stock and restricted stock units to consultants:
 
During the three months ended September 30, 2013, the Company did not grant any restricted stock units to consultants and service providers.
 
During the three months ended September 30, 2013, no restricted stock units held by consultants and service providers were forfeited or vested.
 
Compensation expenses related to restricted stock units granted to consultants were recorded as follows:
 
   
Three months ended September 30,
  
   
2013
    
2012
  
   
Unaudited
  
Research and development expenses
   $ -     $ 120  
General and administrative expenses
     -       273  
    $ -     $ 393